Therapeutic single compounds for osteoarthritis treatment

Hyemi Lee, Xiangyu Zhao, Young Ok Son, Siyoung Yang

Research output: Contribution to journalReview articlepeer-review

19 Scopus citations

Abstract

Osteoarthritis (OA) is an age-related degenerative disease for which an effective disease-modifying therapy is not available. Natural compounds derived from plants have been traditionally used in the clinic to treat OA. Over the years, many studies have explored the treatment of OA using natural extracts. Although various active natural extracts with broad application prospects have been discovered, single compounds are more important for clinical trials than total natural extracts. Moreover, although natural extracts exhibit minimal safety issues, the cytotoxicity and function of all single compounds in a total extract remain unclear. Therefore, understanding single compounds with the ability to inhibit catabolic factor expression is essential for developing therapeutic agents for OA. This review describes effective single compounds recently obtained from natural extracts and the possibility of developing therapeutic agents against OA using these compounds.

Original languageEnglish
Article number131
Pages (from-to)1-18
Number of pages18
JournalPharmaceuticals
Volume14
Issue number2
DOIs
StatePublished - Feb 2021
Externally publishedYes

Keywords

  • Natural compound
  • Osteoarthritis
  • Treatment

Fingerprint

Dive into the research topics of 'Therapeutic single compounds for osteoarthritis treatment'. Together they form a unique fingerprint.

Cite this